| __timestamp | Madrigal Pharmaceuticals, Inc. | Veracyte, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 15746000 | 40786000 |
| Thursday, January 1, 2015 | 13392000 | 47876000 |
| Friday, January 1, 2016 | 9290000 | 52035000 |
| Sunday, January 1, 2017 | 7672000 | 55348000 |
| Monday, January 1, 2018 | 15293000 | 65276000 |
| Tuesday, January 1, 2019 | 22648000 | 82720000 |
| Wednesday, January 1, 2020 | 21864000 | 89118000 |
| Friday, January 1, 2021 | 37318000 | 181193000 |
| Saturday, January 1, 2022 | 48130000 | 174078000 |
| Sunday, January 1, 2023 | 108146000 | 184232000 |
Unleashing insights
In the competitive world of biotechnology, managing operational costs is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Madrigal Pharmaceuticals, Inc. and Veracyte, Inc. over the past decade. From 2014 to 2023, Veracyte consistently outspent Madrigal, with its SG&A expenses peaking at approximately $184 million in 2023, a 350% increase from 2014. Meanwhile, Madrigal's expenses surged by nearly 590% during the same period, reaching around $108 million in 2023. This trend highlights Veracyte's aggressive market expansion and Madrigal's rapid growth trajectory. Understanding these financial dynamics offers valuable insights into each company's strategic priorities and operational efficiencies. As the biotech industry evolves, monitoring such financial metrics will be key to predicting future market leaders.
SG&A Efficiency Analysis: Comparing Regeneron Pharmaceuticals, Inc. and Veracyte, Inc.
Alnylam Pharmaceuticals, Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: BeiGene, Ltd. vs Madrigal Pharmaceuticals, Inc.
Bio-Techne Corporation or Madrigal Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Alpine Immune Sciences, Inc.
Who Optimizes SG&A Costs Better? Madrigal Pharmaceuticals, Inc. or CymaBay Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Madrigal Pharmaceuticals, Inc. and Geron Corporation: SG&A Spending Patterns Compared
Madrigal Pharmaceuticals, Inc. and Dynavax Technologies Corporation: SG&A Spending Patterns Compared
Madrigal Pharmaceuticals, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing TG Therapeutics, Inc. and Veracyte, Inc.
Veracyte, Inc. vs Merus N.V.: SG&A Expense Trends